The Cancer Imaging Archive (TCIA) Public Access

Space shortcuts

Child pages
  • Publications

Versions Compared

Old Version 214

changes.mady.by.user ltarbo01

Saved on

compared with

New Version Current

changes.mady.by.user John Freymann

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Redirectvisiblefalselocationhttps://www.cancerimagingarchive.net/publications/(warning)  Note - This page is no longer being maintained.  Click here to access the new TCIA Publications page.

...


...


When data is submitted to TCIA it undergoes an extensive curation process to assure completeness, proper formatting to facilitate discovery and data reuse and removal of all protected health information.  Once data is released on the public TCIA repository it is Published to the world.  This publication is associated with the creation of a Digital Object Identifier that allows direct access to the data. 

...

  1. Aerts HJ, Velazquez ER, et al. (2014). Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach (Radiomics-Tumor-Phenotypes). TCIA. Saint Louis, MO. (link)
  2. Armato SG and Drukker K, et al. (2015). SPIE-AAPM-NCI Lung Nodule Classification Challenge Dataset. TCIA. Saint Louis, MO. (link)
  3. Bloch N, Rusu M, et al. (2015) NCI-ISBI 2013 Challenge: Automated Segmentation of Prostate Structures (ISBI-MR-Prostate-2013). TCIA. St. Louis, MO. (link)
  4. Colen RR, Wang J, et al. (2014). Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death (Glioblastoma-Genomic-Mapping). TCIA. Saint Louis, MO. (link)

  5. Fedorov A, Schwier M, Clunie D, Herz C, Pieper S, Kikinis R, Tempany C, Fennessy F. (2018) An annotated test-retest collection of prostate multiparametric MRI Scientific Data 5:180281.( link )

  6. Gevaert O, Mitchell LA, et al. (2014). Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features (TCGA-GBM-QI-Radiogenomics). TCIA. Saint Louis, MO. (link)

  7. Gevaert O, Xu J, et al. (2014). Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. TCIA. Saint Louis, MO. (link)
  8. Grove O, Berglund AE, et al. (2015). Data from: Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. TCIA. Saint Louis. MO. (link)

  9. Gutman DA, Cooper LA, et al. (2014). MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set (TCGA-GBM-Radiogenomics). TCIA. Saint Louis, MO. (link)

  10. Huang W, Li X, et al. (2014). Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge. TCIA. Saint Louis, MO. 

  11. Jain R, Poisson LM, et al. (2014). Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor (GBM-MR-NER-Outcomes). TCIA. Saint Louis, MO. (link)

  12. Kalpathy-Cramer J, Napel S, et al. (2015). QIN multi-site collection of Lung CT data with Nodule Segmentations (QIN-LungCT-Seg). TCIA. Saint Louis, MO. (link)

  13. Lee J, Narang S, et al. (2015). Spatial Habitat Features derived from Multiparametric Magnetic Resonance Imaging data from Glioblastoma Multiforme cases (Spatial-Features-MRI-GBM). TCIA. Saint Louis, MO. (link)
  14. Liu F,  Hernandez-Cabronero M, et al. (2016). Image Data Used in the Simulations of "The Role of Image Compression Standards in Medical Imaging: Current Status and Future Trends". TCIA. Saint Louis, MO. (link)  
  15. Mazurowski MA, Zhang J, et al. (2014). Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging. TCIA. Saint Louis, MO. (link)

  16. Messay T, Hardie RC, et al. (2014). Segmentation of Pulmonary Nodules in Computed Tomography Using a Regression Neural Network Approach and its Application to the Lung Image Database Consortium and Image Database Resource Initiative Dataset. TCIA. Saint Louis, MO. (link)

  17. Morris E, Burnside M, et al. (2014). TCGA Breast Phenotype Research Group Data sets (TCGA-Breast-Radiogenomics). TCIA. Saint Louis, MO (link)

  18. Roth H, Lu L, et al. (2015). A new 2.5D representation for lymph node detection in CT. TCIA. Saint Louis, MO. (link)

  19. Shinagare AB, Vikram R, et al. (2015). Radiogenomics of Clear Cell Renal Cell Carcinoma: Preliminary Findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Research Group. TCIA. Saint Louis, MO. (link)

  20. Vallières M, Freeman CR, et al. (2015). Data from: A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. TCIA. Saint Louis, MO. (link)

...

Info
titleThese refer to the QIN-Breast Collection data, created before submission to TCIA
  1. Li X, Dawant BM, Welch EB, Chakravarthy AB, Freehardt D, Mayer I, Kelley M, Meszoely I, Gore JC, Yankeelov TE. Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms. Medical Physics, 2010; 37:2541-52. PMCID: PMC2881925
  2. Atuegwa NC, Gore JC, Yankeelov TE. Using Quantitative Imaging Data to Drive Mathematical Models of Tumor Growth and Treatment Response. Physics in Medicine and Biology, 2010; 55:2429-49. PMCID: PMC2897238
  3. Yankeelov TE, Arlinghaus L, Li X, Gore JC. The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. Seminars in Oncology, 2011; 38:16-25. PMCID: PMC3073543
  4. Arlinghaus L, Li X, Levy M, Smith D, Welch WB, Gore JC, Yankeelov TE. Current and Future Trends in Magnetic Resonance Imaging Assessments of the Response of Breast Tumors to Neoadjuvant Chemotherapy. Journal of Oncology, 2010. pii: 919620. Epub 2010 Sep 29. PMCID: PMC2952974
  5. Arlinghaus LR, Welch EB, Chakravarthy AB, Farley JS, Gore JC, Yankeelov TE. Motion and distortion correction in diffusion-weighted MRI of the breast at 3T. Journal of Magnetic Resonance Imaging, 2011; 33:1063-70. PMCID: PMC3081111
  6. Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE. Magnetic Resonance in the Era of Molecular Imaging of Cancer. Magnetic Resonance Imaging, 2011; 29:587-600. PMCID: PMC3285504
  7. Arlinghaus LR, Li X, Rahman AR, Welch EB, Xu L, Gore JC, Yankeelov TE. On the Relationship Between the Apparent Diffusion Coefficient and Extravascular Extracellular Volume Fraction in Human Breast Cancer. Magnetic Resonance Imaging, 2011; 29:630-8. PMCID: PMC3100356
  8. Smith DS, Welch EB, Li X, Arlinghaus LD, Loveless ME, Koyama T, Gore JC, Yankeelov TE. Quantitative effects of accelerated dynamic contrast enhanced MRI data using compressed sensing. Physics in Medicine and Biology, 2011; 56:4933-46. PMCID: PMC3192434
  9. Li, X, Welch EB, Chakravarthy B, Mayer I, Meszeoly I, Kelley M, Means-Powell J, Gore JC, Yankeelov TE. A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer. Physics in Medicine and Biology, 2011; 56:5753-69. PMCID: PMC3176673


Collection: Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge (QIN Breast DCE-MRI)

  1. Nowaková J, Prílepok M, Snášel V. Medical Image Retrieval Using Vector Quantization and Fuzzy S-tree. Journal of Medical Systems. 2017;41(2):18. (link)

Collection: QIN GBM DCE-MRI - Deprecated

  1. Beers, A., Chang, K., Brown, J., Zhu, X., Sengupta, D., Willke, T. L., Gerstner, E., Rosen, B., Kalpathy-Cramer, J. (2018). Anatomical DCE-MRI phantoms generated from glioma patient data. SPIE Medical Imaging. 105732(V). Houston: SPIE. DOI:10.1117/12.2294961
  2. Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Mintz A, Kostakoglu L, Eikman EA, Prah MA, Ellingson BM, Ratai EM, Schmainda KM, Sorensen G, Barboriak DP,  Mankoff DA. ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using 18F-FMISO PET and MRI. Clin Cancer Res. 2016 Oct 15;22(20):5079-5086. DOI:10.1158/1078-0432.CCR-15-2529
  3. Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Mintz A, Kostakoglu L, Eikman EA, Prah M, Schmainda KM, Sorensen GA, Barboriak D,  Mankoff DA. ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using 18F-FMISO PET and MRI. J Clin Oncol 33(Suppl):2024. 2015.
  4. Fink JR, Zhang Z, Gerstner ER, Muzi M, Kostakoglu L, Mintz A, Eikman EA, Barboriak D,  Mankoff DA. ACRIN 6684: Multicenter phase II assessment of tumor hypoxia in glioblastoma using 18F-Fluoromisonidazole (FMISO) PET and MRI. J Nucl Med 56(Suppl3):325. 2015.
  5. Fink JR, Muzi M, Peck M,  Krohn KA. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging. J Nucl Med 56(10):1554-1561. 2015.
  6. Muzi M, Fink JR, Richards TL, Marro KI, Wong T, Muzi JP, Eary JF, Rockhill JK,  Krohn KA. Evaluation of PET and MR measurements to examine progression in glioma patients. J Nucl Med 55(Suppl1):1512-. 2014.

...

Info
titleThese refer to the RIDER Collections data, created before submission to TCIA
  1. Meyer CR, Armato SG III, Fenimore CP, McLennan G, Bidaut LM, Barboriak DP, Gavrielides MA, Jackson EF, McNitt-Gray MF, Kinahan PE, Petrick N, Zhao B. Quantitative imaging to assess tumor response to therapy: Common themes of measurement, truth data and error sources. Translational Oncology 2: 198–210, 2009. (link)
  2. McNitt-Gray MF, Bidaut LM, Armato SG III, Meyer CR, Gavrielides MA, Fenimore CP, McLennan G, Petrick N, Zhao B, Reeves AP, Beichel R, Kim H-J, Kinnard L. CT assessment of response to therapy: Tumor volume change measurement, truth data and error.Translational Oncology2009. 2:216–222. (link)
  3. Kinahan PE, Doot RK, Wanner-Roybal M, Bidaut LM, Armato SG III, Meyer CR, McLennan G.PET/CT assessment of response to therapy: Tumor change measurement, truth data and error.Translational Oncology 2:223–230, 2009. (link)
  4. Jackson EF, Barboriak DP, Bidaut LM, Meyer CR. Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sources.Translational Oncology 2009 Dec;2(4):211-5. PubMed PMID: 19956380; PubMed Central PMCID: PMC2781079. (link)
  5. Armato SG 3rd, Meyer CR, Mcnitt-Gray MF, McLennan G, Reeves AP, Croft BY, Clarke LP;RIDER Research Group. The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software.Clin Pharmacol Ther. 2008 Oct;84(4):448-56. PubMed PMID: 18754000. (link)

Collection: A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities (Soft-tissue-Sarcoma)

  1. Lee, I., Im, H.-J., Solaiyappan, M., & Cho, S. Y. (2017). Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma. EJNMMI Physics, 4(22), 1-10. DOI 10.1186/s40658-017-0189-0
  2. Hermessi, H., Mourali, O., & Zagrouba, E. (2019). Deep feature learning for soft tissue sarcoma classification in MR images via transfer learning. Expert Systems with Applications, 120, 116-127. DOI: 10.1016/j.eswa.2018.11.025 

Collection: SPIE-AAPM-NCI Lung Nodule Classification Challenge Dataset (SPIE-AAPM Lung CT Challenge)

  1. Park SY and Sargent D. Tumor propagation model using generalized hidden Markov model. Proc. SPIE 10133, Medical Imaging 2017: Image Processing, 101331G February 24, 2017); 10.1117/12.2254583
  2. Sargent D, Park S-Y. Semi-automatic 3D lung nodule segmentation in CT using dynamic programming. Proc. SPIE 10133, Medical Imaging 2017: Image Processing, 101332R (February 24, 2017) DOI: 10.1117/12.2254575
  3. Nishio M, Nagashima C. Computer-aided Diagnosis for Lung Cancer: Usefulness of Nodule Heterogeneity. Academic Radiology. 2017;24(3):328-36. (link)

Collection: SPIE-AAPM-NCI PROSTATEx Challenges (PROSTATEx)

  1. A Chaddad, T Niazi, S Probst, F Bladou, M Anidjar, B Bahoric. (2018) Predicting Gleason Score of Prostate Cancer Patients using Radiomic Analysis. Frontiers in Oncology. DOI: 10.3389/fonc.2018.00630

...

  1. Han, L., & Kamdar, M. R. (2018). MRI to MGMT: Predicting methylation status in glioblastoma patients using convolutional recurrent neural networks. Pacific Symposium on Biocomputing, 23, 331-342. (link)

  2. ParthaSarathi, M., & Ansari, M. A. (2017). Multimodal retrieval framework for brain volumes in 3D MR volumes. Journal of Medical and Biological Engineering, 1-12. DOI:10.1007/s40846-017-0287-4

  3. Liu, Y., Xu, X., Yin, L., Zhang, X., Li, L., & Lu, H. (2017). Relationship between glioblastoma heterogeneity and survival time: An MR imaging texture analysis. American Journal of Neuroradiology, 1-7. DOI:10.3174/ajnr.A5279.

  4. Beig N, Patel J, Prasanna P, et al. Radiogenomic analysis of hypoxia pathway reveals computerized MRI descriptors predictive of overall survival in Glioblastoma. SPIE Medical Imaging; 2017; 10134:1-10. International Society for Optics and Photonics. DOI:10.1117/12.2255694

  5. Lee, J.K., Wang, J., Sa, J.K., et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nature Genetics.(2017) DOI: 10.1038/ng.3806

  6. Cui Y, Ren S, Tha KK, Wu J, Shirato H, Li R. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. European Radiology. 2017:1-10. (link)

  7. Kanas VG, Zacharaki EI, Thomas GA, Zinn PO, Megalooikonomou V, Colen RR. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Computer Methods and Programs in Biomedicine. 2017;140:249-57.(link)

  8. Czarnek N, Clark K, Peters KB, Mazurowski MA. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. Journal of Neuro-Oncology. 2017:1-8. (link)

  9. Chaddad A, Desrosiers C, Toews M, editors. Radiomic analysis of multi-contrast brain MRI for the prediction of survival in patients with glioblastoma multiforme. Engineering in Medicine and Biology Society (EMBC), 2016 IEEE 38th Annual International Conference; 2016.

  10. Prasanna, P., Patel, J., Partovi, S. et al. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.  Eur Radiol (2016) pp 1–10. DOI:10.1007/s00330-016-4637-3

  11. Mulvey M, Muhyadeen S,  Sinha U. Classification of Glioblastoma Multiforme Molecular Subtypes Using Three-Dimensional Multi-Modal MR Imaging Features. Med. Phys. 43, 3373 (2016); (link)

  12. Ren X, Cui Y, Gao H,  Li, R. Identifying High-Risk Tumor Volume Based On Multi-Region and Integrated Analysis of Multi-Parametric MR Images for Prognostication of Glioblastoma. Med. Phys. 43, 3751 (2016); (link)
  13. Dunn WD Jr,  Aerts HJWL, et al.  Assessing the Effects of Software Platforms on Volumetric Segmentation of Glioblastoma.   J   Neuroimaging Psychiatry Neurol 2016. 1(2): 64-72.
  14. Upadhaya T, Morvan Y, et al. Prognosis classification in glioblastoma multiforme using multimodal MRI derived heterogeneity textural features: impact of pre-processing choices. Proc. SPIE 9785, Medical Imaging 2016: Computer-Aided Diagnosis, 97850W (March 24, 2016); (link)

  15. Upadhaya T, Morvan Y, et al. Prognostic value of multimodal MRI tumor features in Glioblastoma multiforme using textural features analysis. In Biomedical Imaging (ISBI), 2015 IEEE 12th International Symposium on, pp. 50-54. IEEE, 2015.

  16. Upadhaya T, Morvan Y, et al. A framework for multimodal imaging-based prognostic model building: Preliminary study on multimodal MRI in Glioblastoma Multiforme. IRBM. 2015 Nov 30;36(6):345-50.

  17. Reza SM, Mays R, Iftekharuddin KM, editors. Multi-fractal detrended texture feature for brain tumor classification. SPIE Medical Imaging; 2015: International Society for Optics and Photonics.

  18. Nabizadeh N, Kubat M. Brain tumors detection and segmentation in MR images: Gabor wavelet vs. statistical features. Computers & Electrical Engineering. 2015.

  19. Natteshan N, Jothi JAA. Automatic Classification of Brain MRI Images Using SVM and Neural Network Classifiers.  Advances in Intelligent Informatics: Springer; 2015. p. 19-30. (link)

  20. Zhang J, Barboriak DP, Hobbs H, Mazurowski MA. A fully automatic extraction of magnetic resonance image features in Glioblastoma patients. Medical physics. 2014;41(4):042301.

  21. Wangaryattawanich P, Wang J, Thomas GA, Chaddad A, Zinn PO, Colen RR, editors. Survival analysis of pre-operative GBM patients by using quantitative image features. Control, Decision and Information Technologies (CoDIT), 2014 International Conference on; 2014: IEEE.

  22. Colen RR, Wang J, Singh SK, Gutman DA, Zinn PO. Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death. Radiology. 2014.

  23. Colen RR, Vangel M, Wang J, Gutman DA, Hwang SN, Wintermark M, Rajan J, Jilwan-Nicola M, Chen JY, Raghavan P, Holder CA, Rubin D, Huang E, Kirby J, Freymann J, Jaffee CC, Flanders A, Zinn PO. Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project.BMC Medical Genomics, 2014. 7(1):30. DOI: 10.1186/1755-8794-7-30 (link)
  24. Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Chesier SH, Napel S, Zaharchuk G, Plevritis SK. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features. Radiology, 2014. DOI: 10.1148/radiol.14131731 (link)
  25. Mazurowski MA, Zhang J, Peters KB, and Hobbs H. Computer-extracted MR imaging features are associated with survival in glioblastoma patients. Journal of Neuro-Oncology, 2014. 120(3):483–488 DOI: 10.1007/s11060-014-1580-5 (link)
  26. Jain R, Poisson L, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Jaffe C, Mikkelsen T, Flanders A. Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor. Radiology. 2014 Aug;272(2):484-93. DOI: 10.1148/radiol.14131691. Epub 2014 Mar 19. 2014 (link)
  27. Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, et al. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. Journal of Neuroradiology, July 2014. DOI: 10.1016/j.neurad.2014.02.006
  28. Wassal E, Zinn P, Colen R. Diffusion and conventional MR imaging genomic biomarker signature for EGFR mutation identification in glioblastoma. Neuro-Oncology. 2014;16(suppl 5):v156-v7.

  29. Wassal E, Zinn P, Colen R. Diffusion and conventional and MR imaging genomic biomarker signature predicts IDH-1 mutation in glioblastoma patients. Neuro-Oncology. 2014;16(suppl 5):v157-v.

  30. Kwon D, Shinohara RT, Akbari H, Davatzikos C. Combining Generative Models for Multifocal Glioma Segmentation and Registration.  Medical Image Computing and Computer-Assisted Intervention–MICCAI 2014: Springer; 2014. p. 763-70.

  31. Amer A, Zinn P, Colen R. Immediate post operative volume of abnormal flair signal predicts patient survival in glioblastoma patients. Neuro-Oncology. 2014;16(suppl 5):v138-v.
  32. Amer A, Zinn P, Colen R. Immediate post-resection pericavitarian DWI hyperintensity in glioblastoma patients is predictive of patient outcome. Neuro-Oncology. 2014;16(suppl 5):v138-v9.
  33. Gutman DA, Cooper LAD, Hwang SN, Holder CA, Gao J, Aurora TD, Dunn WD, Scarpace L, Mikkelsen T, Jain R, Wintermark M, Jilwan M, Raghavan P, Huang E, Clifford RJ, Monqkolwat P, Kleper V, Freymann J, Kirby J, Zinn PO, Moreno CS, Jaffe C, Colen R, Rubin DL, Saltz J, Flanders A, Brat DJ. MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set. Radiology. 2013 May:267(2):560-569,DOI:10.1148/radiol.13120118 (link)
  34. Jain R, Poisson L, Narang J, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Brat DJ, Jaffe C, Mikkelsen T. Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers. Radiology, 2013 Apr:267(1):212 –220, DOI:10.1148/radiol.12120846 (link)
  35. Mazurowski MA, Desjardins A, Malof JM. Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro-oncology, 2013. 15(10):1389-1394 (link)
  36. Zinn PO, Colen RR. Imaging Genomic Mapping in Glioblastoma. Neurosurgery 60:126-130. Aug 2013 (link)
  37. Jain R, Poisson L, Narang J, Scarpace L, Rosenblum ML, Rempel S, Mikkelson T. Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study. American Journal of Neuroradiology, 2012. 33(7):1343-1348 [Epub ahead of print] (link)
  38. Zinn PO, Sathyan P, Mahajan B, Bruyere J, Hegi M, et al. A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature. PLoS ONE, 2012 7(8): e41522. DOI:10.1371/journal.pone.0041522 (link)
  39. Zinn PO, Majadan B, Sathyan P, Singh SK, Majumder S, et al. Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme. PLoS ONE, 2011 6(10): e25451. DOI:10.1371/journal.pone.0025451 (link)

  40. Wangaryattawanich, P., M. Hatami, et al.  "Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival." Neuro-oncology, (2015): nov117 .

  41. Kuo, J. S., K. B. Pointer, et al. (2015). "139 Human Ether-a-Go-Go-Related-1 Gene (hERG) K+ Channel as a Prognostic Marker and Therapeutic Target for Glioblastoma." Neurosurgery 62: 210-211.

  42. Zinn, P. O., M. Hatami, et al. (2015). "138 Diffusion MRI ADC Mapping of Glioblastoma Edema/Tumor Invasion and Associated Gene Signatures." Neurosurgery 62: 210.

  43. Steed, T., J. Treiber, et al. (2015). "Iterative Probabilistic Voxel Labeling: Automated Segmentation for Analysis of The Cancer Imaging Archive Glioblastoma Images." American Journal of Neuroradiology 36(4): 678-685.

  44. Lee, J., S. Narang, et al. (2015). "Associating spatial diversity features of radiologically defined tumor habitats with epidermal growth factor receptor driver status and 12-month survival in glioblastoma: methods and preliminary investigation." Journal of Medical Imaging 2(4): 041006-041006.

  45. Itakura, H., A. S. Achrol, et al. (2015). "Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities." Science Translational Medicine 7(303): 303ra138-303ra138.

  46. Cui, Y., K. K. Tha, et al. (2015). "Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images." Radiology: 150358.

  47. Lee, J., S. Narang, et al. (2015). "Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme." PloS one 10(9): e0136557.

  48. Rios Velazquez E, Meier R, Dunn WD Jr, Alexander B, Wiest R, Bauer S, Gutman DA, Reyes M, Aerts HJ. "Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features." Sci Rep. 2015 Nov 18;5:16822. DOI: 10.1038/srep16822.

Collection: The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma Collection (TCGA-KIRC) 

  1. Nguyen, G. K., Mellnick, V. M., Yim, A. K.-Y., Salter, A., & Ippolito, J. E. (2018). Synergy of sex differences in visceral fat measured with CT and tumor metabolism helps predict overall survival in patients with Renal Cell Carcinoma. Radiology, 287(3), 884-892. DOI:10.1148/radiol.2018171504

  2. Liu X, Swen JJ, Diekstra MHM, Boven E, Castellano D, Gelderblom H, Mathijssen RHJ, Vermeulen SH, Oosterwijk E, Junker K, Roessler M, Alexiusdottir K, Sverrisdottir A, Radu MT, Ambert V, Eisen T, Warren A, Rodriguez-Antona C, Garcia-Donas J, Bohringer S, Koudijs KKM, Kiemeney L, Rini BI, Guchelaar HJ. (2018) A genetic polymorphism in CTLA-4 is associated with overall survival in sunitinib-treated patients with clear cell metastatic renal cell carcinoma. Clin Cancer Res 2018. DOI: 10.1158/1078-0432.CCR-17-2815

    Chen X, Zhou Z, Thomas K, Wang J. Predicting Gene Mutations in Renal Cell Carcinoma Based On CT Imaging Features: Validation Using TCGA-TCIA Datasets. Med. Phys. 43, 3705 (2016); (link)
  3. Zhu H, Chen H, Lin Z, Shi G, Lin X, Wu Z, Zhang X. Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system. Oncotarget. 2016. (link)
  4. Shinagare AB, Vikram R, Jaffe C, Akin O, Kirby J, Huang E, Freymann J, Sainani NI, Sadow CA, Bathala TK. Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas–Renal Cell Carcinoma (TCGA–RCC) Imaging Research Group. Abdominal imaging. 2015:1-9.

Collection: The Cancer Genome Atlas Low Grade Glioma Collection (TCGA-LGG)

  1. TA Juratli, SS Tummala, A Riedl, D Daubner, S Hennig, T Penson, A Zolal, C Thiede, G Schackert, D Krex, JJ Miller, DP Cahill. (2018) Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.Journal of Neuro-Oncology, 2018. DOI:  10.1007/s11060-018-03034-6

  2. Halani, S. H., Yousefi, S.; Vega, J. V.; Rossi, M. R.; Zhao, Z.; Amrollahi, F.; Holder, C. A.; Baxter-Stoltzfus, A.; Eschbacher, J.; Griffith, B.; Olson, J. J.; Jiang, T.; Yates, J. R.; Eberhart, C. G.; Poisson, L. M.; Cooper, L. A. D.; Brat, D. J. (2018). Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways. Precision Oncology. DOI: 10.1038/s41698-018-0067-9 

  3. Liu, Z., Zhang, T., Jiang, H., Xu, W., & Zhang, J. (2018). Conventional MR-based preoperative nomograms for prediction of IDH/1p19q subtype in low-grade glioma. Academic Radiology. DOI: 10.1016/j.acra.2018.09.022 

Collection: The Cancer Genome Atlas Lung Adenocarcinoma Collection (TCGA-LUAD)

  1. Dara S, Tumma P, Eluri N, Kancharla G. Feature Extraction In Medical Images by Using Deep Learning Approach. International Journal of Pure and Applied Mathematics. 2018;120(6):305-12.

  2. Pathak, Y., Arya, K. V., & Tiwari, S. (2018). An efficient low-dose CT reconstruction technique using partial derivatives based guided image filter. Multimedia Tools and Applications, 1-20. DOI: 10.1007/s11042-018-6840-5 

Collection: The Cancer Genome Atlas Lung Squamous Cell Carcinoma Collection (TCGA-LUSC)

  1. Walter, R., Rozynek, P., Casjens, S., Werner, R., Mairinger, F., Speel, E., Zur Hausen, A., Meier, S., Wohlschlaeger, J., Theegarten, D., Behrens, T., Schmid, K. W., Bruning, T., Johnen, G. (2018). Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer. PLoS One, 13(5), e0195716. DOI:10.1371/journal.pone.0195716

Collection: Data from 4D Lung Imaging of NSCLC Patients (4D-Lung) 

  1. Woodruff, H. C., Shieh, C.-C., Hegi-Johnson, F., Keall, P. J. and Kipritidis, J. (2017), Quantifying the reproducibility of lung ventilation images between 4-Dimensional Cone Beam CT and 4-Dimensional CT. Med. Phys. DOI: 10.1002/mp.12199
  2. Hugo GD, Weiss E,  Sleeman WC, Balik S, Keall PJ, Lu J, Williamson JF. A longitudinal four-dimensional computed tomography and cone beam computed tomography dataset for image-guided radiation therapy research in lung cancer. Med. Phys. (2017) DOI: 10.1002/mp.12059

...